Navigation Links
GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
Date:12/6/2008

on of PROMACTA and, during therapy with PROMACTA, regularly monitor patients for signs and symptoms of cataracts.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline at www.gsk.com.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2007.

Note to Editors

PROMACTA(R) is a registered trademark of GlaxoSmithKline group of companies in the United States.

REVOLADE(R) is a registered trademark of GlaxoSmithKline group of companies and is the proposed trade name in Europe.

To access the latest GSK news, visit http://us.gsk.com/.

References:

1. National Heart, Lung, and Blood Institute. Diseases and Conditions Index. http://www.nhlbi.nih.gov/health/dci/Diseases/Itp/ITP_WhatIs.html. Accessed November 12, 2007.

2. Feudjo-Tepie M, Robinson N, Bennett D. Prevalence estimates of adult chronic idiopathic thrombocytopenic purpura (ITP). J Thromb Haemost. 2008; 6(4): 711 - 712.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
2. GEN Reports on the Trend Toward Predictive Toxicogenomics
3. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
4. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
7. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
8. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
10. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
11. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... a Little Help ... Series,PSA Expands Partnership Between VH1 and Nothing But Nets to Prevent Malaria ... in Africa, ... very serious issue in a new Public,Service Announcement (PSA) created by VH1 for Nothing But ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today announced ... consortium led by the University of North Carolina ... Bill & Melinda Gates Foundation,(the "Gates Foundation"), to ... leishmania. This grant is part of the $22.6,million ...
Cached Medicine Technology:'Best Week Ever' for Nothing But Nets 2'Best Week Ever' for Nothing But Nets 3Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:4/18/2014)... Ky. (April 21, 2014) -- A group of ... Medicine and the Sanders-Brown Center on Aging has ... depression and neuropsychological function in Parkinson,s disease (PD). ... Research , the study, which assessed cognitive function ... that the dopamine replacement therapy commonly used to ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial ... School of Medicine, variations of the adiponectin gene, which ... womans risk of developing breast cancer. This discovery is ... it could help experts develop a future genetic testing ...
... NEW YORK (April 25, 2008) -- Heart failure patients ... first to be implanted with the HeartMate II LVAS ... that helps weak hearts pump blood -- that has ... 21 for broad use as bridge to transplantation. As ...
... County Sees Sharp Rise in Gonorrhea Cases, HARRISBURG, Pa., ... of cases of Gonorrhea last year in Delaware County,the Pennsylvania ... of 15 and 24 be routinely screened for the,disease, as ... Gonorrhea grew to 921 in 2007 from 513,the year before., ...
... With an aggressive growth plan in,effect for 2008, YoNaturals ... big step in their expansion efforts with new,vending locations ... of 2006, YoNaturals has maintained a strong,dedication toward changing ... have experienced thus far is in large part due ...
... Winner Renee Zellweger ("Chicago") Reteams with Craig Zadan and Neil Meron, Executive ... Producers for the Sony Pictures Television Project, Based ... a Doctor,s Dramatic Quest to Develop the Lifesaving Breast Cancer ... Drug Herceptin ...
... The Lupus Foundation of,America joins a coalition of approximately ... on May 10. More than 1.5 million,Americans and at ... they struggle daily with the often-debilitating health,consequences of the ... of an unbalanced immune system that can become,destructive to ...
Cached Medicine News:Health News:Study shows gene variations may predict risk of breast cancer in women 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 3Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 4Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 5Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Provides reliable suction for surgical cases with larger amounts of drainage....
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube...
Medicine Products: